GlaxoSmithKline
GSK
#216
Rank
A$144.63 B
Marketcap
A$71.40
Share price
-2.18%
Change (1 day)
31.28%
Change (1 year)

GlaxoSmithKline (GSK) - Total debt

Total debt on the balance sheet as of September 2025 : A$35.93 Billion

According to GlaxoSmithKline's latest financial reports the company's total debt is A$35.93 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

GlaxoSmithKline - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$34.26 B1.71%
2023-12-31A$33.69 B-9.7%
2022-12-31A$37.31 B-17.1%
2021-12-31A$45.00 B-6.48%
2020-12-31A$48.12 B-15.77%
2019-12-31A$57.13 B21.67%
2018-12-31A$46.96 B58.75%
2017-12-31A$29.58 B-8.02%
2016-12-31A$32.16 B-4.93%
2015-12-31A$33.83 B-5.32%
2014-12-31A$35.73 B5.91%
2013-12-31A$33.73 B18.53%
2012-12-31A$28.46 B26.02%
2011-12-31A$22.58 B-1.57%
2010-12-31A$22.94 B-21.64%
2009-12-31A$29.28 B-12.91%
2008-12-31A$33.62 B39.85%
2007-12-31A$24.04 B76.33%
2006-12-31A$13.63 B-21.43%
2005-12-31A$17.35 B17.38%
2004-12-31A$14.78 B20.57%
2003-12-31A$12.26 B-7.19%
2002-12-31A$13.21 B9.65%
2001-12-31A$12.05 B11.96%
2000-12-31A$10.76 B24.7%
1999-12-31A$8.63 B1.83%
1998-12-31A$8.47 B11.23%
1997-12-31A$7.61 B8.94%
1996-12-31A$6.99 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
A$49.14 B 36.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$91.63 B 155.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.30 B 73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$48.22 B 34.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$38.44 B 7.00%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
A$25.71 B-28.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
A$0.42 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA